View in EDS

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.

Saved in:
Bibliographic Details
Title: Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
Authors: Goodall RL; MRC Clinical Trials Unit at UCL, University College London, London, UK. Electronic address: r.goodall@ucl.ac.uk., Nunn AJ; MRC Clinical Trials Unit at UCL, University College London, London, UK., Meredith SK; MRC Clinical Trials Unit at UCL, University College London, London, UK., Bayissa A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Bhatnagar AK; Rajan Babu Institute for Pulmonary Medicine & Tuberculosis, Delhi, India., Chiang CY; Department of Internal Medicine, Wan Fang Hospital, Taipei, Taiwan; School of Medicine, Taipei Medical University, Taipei, Taiwan; International Union Against Tuberculosis and Lung Disease, Paris, France., Conradie F; Empilweni TB Hospital, Gqeberha (Port Elizabeth), South Africa., Gopalan N; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Gurumurthy M; Vital Strategies, Singapore., Kirenga B; Makerere University Lung Institute, Mulago Hospital, Kampala, Uganda., Kiria N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Meressa D; St Peter's Tuberculosis Specialized Hospital and Global Health Committee, Addis Ababa, Ethiopia., Moodliar R; THINK: Tuberculosis & HIV Investigative, Doris Goodwin Hospital, Pietermaritzburg, South Africa., Ngubane N; King Dinuzulu Hospital Complex, Durban, South Africa., Rassool M; Clinical HIV Research Unit, Helen Joseph Hospital, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa., Sanders K; MRC Clinical Trials Unit at UCL, University College London, London, UK., Solanki R; B J Medical College, Ahmedabad, India., Squire SB; Liverpool School of Tropical Medicine, Liverpool, UK., Teferi M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Torrea G; Institute of Tropical Medicine, Antwerp, Belgium., Tsogt B; Mongolian Anti-Tuberculosis Coalition, Ulaanbaatar, Mongolia., Tudor E; Institute of Phthisiopneumology 'Chiril Draganiuc', Chisinau, Moldova., Van Deun A; Institute of Tropical Medicine, Antwerp, Belgium., Rusen ID; Vital Strategies, New York, NY, USA.
Corporate Authors: STREAM study collaborators
Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Dec; Vol. 12 (12), pp. 975-987. Date of Electronic Publication: 2024 Oct 01.
Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39366400
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goodall+RL%22">Goodall RL</searchLink>; MRC Clinical Trials Unit at UCL, University College London, London, UK. Electronic address: r.goodall@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Nunn+AJ%22">Nunn AJ</searchLink>; MRC Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Meredith+SK%22">Meredith SK</searchLink>; MRC Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bayissa+A%22">Bayissa A</searchLink>; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Bhatnagar+AK%22">Bhatnagar AK</searchLink>; Rajan Babu Institute for Pulmonary Medicine & Tuberculosis, Delhi, India.<br /><searchLink fieldCode="AU" term="%22Chiang+CY%22">Chiang CY</searchLink>; Department of Internal Medicine, Wan Fang Hospital, Taipei, Taiwan; School of Medicine, Taipei Medical University, Taipei, Taiwan; International Union Against Tuberculosis and Lung Disease, Paris, France.<br /><searchLink fieldCode="AU" term="%22Conradie+F%22">Conradie F</searchLink>; Empilweni TB Hospital, Gqeberha (Port Elizabeth), South Africa.<br /><searchLink fieldCode="AU" term="%22Gopalan+N%22">Gopalan N</searchLink>; ICMR-National Institute for Research in Tuberculosis, Chennai, India.<br /><searchLink fieldCode="AU" term="%22Gurumurthy+M%22">Gurumurthy M</searchLink>; Vital Strategies, Singapore.<br /><searchLink fieldCode="AU" term="%22Kirenga+B%22">Kirenga B</searchLink>; Makerere University Lung Institute, Mulago Hospital, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Kiria+N%22">Kiria N</searchLink>; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.<br /><searchLink fieldCode="AU" term="%22Meressa+D%22">Meressa D</searchLink>; St Peter's Tuberculosis Specialized Hospital and Global Health Committee, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Moodliar+R%22">Moodliar R</searchLink>; THINK: Tuberculosis & HIV Investigative, Doris Goodwin Hospital, Pietermaritzburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Ngubane+N%22">Ngubane N</searchLink>; King Dinuzulu Hospital Complex, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Rassool+M%22">Rassool M</searchLink>; Clinical HIV Research Unit, Helen Joseph Hospital, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Sanders+K%22">Sanders K</searchLink>; MRC Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Solanki+R%22">Solanki R</searchLink>; B J Medical College, Ahmedabad, India.<br /><searchLink fieldCode="AU" term="%22Squire+SB%22">Squire SB</searchLink>; Liverpool School of Tropical Medicine, Liverpool, UK.<br /><searchLink fieldCode="AU" term="%22Teferi+M%22">Teferi M</searchLink>; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Torrea+G%22">Torrea G</searchLink>; Institute of Tropical Medicine, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Tsogt+B%22">Tsogt B</searchLink>; Mongolian Anti-Tuberculosis Coalition, Ulaanbaatar, Mongolia.<br /><searchLink fieldCode="AU" term="%22Tudor+E%22">Tudor E</searchLink>; Institute of Phthisiopneumology 'Chiril Draganiuc', Chisinau, Moldova.<br /><searchLink fieldCode="AU" term="%22Van+Deun+A%22">Van Deun A</searchLink>; Institute of Tropical Medicine, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Rusen+ID%22">Rusen ID</searchLink>; Vital Strategies, New York, NY, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22STREAM+study+collaborators%22">STREAM study collaborators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101605555%22">The Lancet. Respiratory medicine</searchLink> [Lancet Respir Med] 2024 Dec; Vol. 12 (12), pp. 975-987. <i>Date of Electronic Publication: </i>2024 Oct 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101605555 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-2619 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222132600%22">22132600 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Respir Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39366400
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2213-2600(24)00186-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 975
    Titles:
      – TitleFull: Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goodall RL
      – PersonEntity:
          Name:
            NameFull: Nunn AJ
      – PersonEntity:
          Name:
            NameFull: Meredith SK
      – PersonEntity:
          Name:
            NameFull: Bayissa A
      – PersonEntity:
          Name:
            NameFull: Bhatnagar AK
      – PersonEntity:
          Name:
            NameFull: Chiang CY
      – PersonEntity:
          Name:
            NameFull: Conradie F
      – PersonEntity:
          Name:
            NameFull: Gopalan N
      – PersonEntity:
          Name:
            NameFull: Gurumurthy M
      – PersonEntity:
          Name:
            NameFull: Kirenga B
      – PersonEntity:
          Name:
            NameFull: Kiria N
      – PersonEntity:
          Name:
            NameFull: Meressa D
      – PersonEntity:
          Name:
            NameFull: Moodliar R
      – PersonEntity:
          Name:
            NameFull: Ngubane N
      – PersonEntity:
          Name:
            NameFull: Rassool M
      – PersonEntity:
          Name:
            NameFull: Sanders K
      – PersonEntity:
          Name:
            NameFull: Solanki R
      – PersonEntity:
          Name:
            NameFull: Squire SB
      – PersonEntity:
          Name:
            NameFull: Teferi M
      – PersonEntity:
          Name:
            NameFull: Torrea G
      – PersonEntity:
          Name:
            NameFull: Tsogt B
      – PersonEntity:
          Name:
            NameFull: Tudor E
      – PersonEntity:
          Name:
            NameFull: Van Deun A
      – PersonEntity:
          Name:
            NameFull: Rusen ID
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2213-2619
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The Lancet. Respiratory medicine
              Type: main
ResultId 1